Navigation Links
SCPC Praises Bipartisan Collins-Loebsack Letter Advancing Investigation of PBMs' Anti-Competitive, Non-Transparent Pricing Practices
Date:2/26/2016

WASHINGTON, Feb. 26, 2016 /PRNewswire-USNewswire/ -- The Senior Care Pharmacy Coalition (SCPC) today praised U.S. Reps. Doug Collins (R-GA) and Dave Loebsack (D-IA) for issuing a letter with fourteen colleagues urging the Chairmen of the U.S. House Energy and Commerce, Ways and Means and Armed Services Committees to examine the importance of passing the MAC Transparency Act (H.R. 244) in advancing payment transparency in regard to how Pharmacy Benefit Managers (PBMs) reimburse a variety of pharmacy groups, including LTC pharmacies, for generic drugs administered to patients.

"Current non-transparent PBM pricing practices make it impossible for LTC pharmacies to predict how they will be reimbursed for the generic drugs they dispense under Medicare Part D, and passage of the MAC Transparency Act would be a strong first step towards more equitable, fair and transparent reimbursement for pharmacies dispensing generic drugs to seniors," said Alan G. Rosenbloom, President and CEO of SCPC.

Under Medicare Part D – the largest payer for prescription medications in LTC facilities – the PBMs that administer Prescription Drug Plans (PDPs), and which often are owned by the PDPs or a shared parent company and frequently have links to major chain drug stores, use a Maximum Allowable Cost (MAC) pricing formula to establish reimbursement rates for a majority of generic drugs independent LTC pharmacies dispense to elderly Medicare beneficiaries.

Rosenbloom praised Collins and Loebsack for their ongoing efforts to spotlight how PBMs surreptitiously develop and alter their MAC pricing lists without disclosing how they determine which drugs to include on the lists, how those prices are established, or how frequently those prices are updated -- rendering the process completely opaque.

"MAC pricing presents serious challenges to independent LTC pharmacies as it becomes difficult if not impossible to forecast revenues, and to assure resources sufficient to provide the extensive array of services LTC patients require, and which federal law mandates LTC pharmacies to provide," Rosenbloom continued.

Rosenbloom said the SCPC will continue to focus attention on anti-competitive PBM pricing practices by pointing to Avalere Health pharmacy data, which SCPC argues demonstrates PBMs' pricing methodology leads to arbitrary and capricious reimbursement.

"We will continue our effort to ensure federal lawmakers and regulators are aware of this unique data that sheds light on anti-competitive PBM pricing practices and their false claim that the pricing methodology used to reimburse LTC pharmacies and others for prescribed generic drugs is market-based," he said. "To the contrary, we believe the data demonstrates PBMs' pricing methodology leads to arbitrary and capricious reimbursement, and we are pleased it is helping to drive more aggressive congressional scrutiny of PBMs."

The SCPC represents companies that own and operate independent long-term care pharmacies (LTCPs) in 40 states, serving over 400,000 residents in skilled nursing facilities (SNFs) and assisted living facilities (ALFs) daily. Learn more at seniorcarepharmacies.org.

 


'/>"/>
SOURCE Senior Care Pharmacy Coalition
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. SCPC Praises Broad Bipartisan Support in U.S. House for 21st Century Cures Act
2. National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing
3. Consumer Watchdog Praises Passage of Bill that Requires Physicians Check Prescription Drug Database Before Prescribing Powerful, Addictive Medications
4. West Virginia Retailers Association praises NPLEx
5. Muhammad Ali Parkinson Centers Youngest Patient Praises New "Sci-Fi" Procedure
6. Ex-White House Drug Spokesman Robert Weiner And Daniel Sordello Assert "Rewriting Drug Policy" Bipartisan Presidential Campaign And Debate Issue
7. Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee
8. PCMA Supports Bipartisan Legislation Creating Safe Pharmacy Networks to Reduce Prescription Drug Abuse in Medicare
9. Telesta Therapeutics Receives Complete Response Letter from FDA
10. Amarantus Enters Into Letter of Intent to Merge Diagnostics Business Unit Into Avant Diagnostics
11. VolitionRx Releases Annual Shareholder Update Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2019)... Pa. (PRWEB) , ... June 19, 2019 , ... ... nuclear receptor and in vitro toxicology testing solutions, announced the addition of the ... kit expands INDIGO’s existing in vitro toxicology offerings and allows researchers to perform ...
(Date:6/18/2019)... ... June 18, 2019 , ... MY ... W Olympic Blvd Suite 350 Los Angeles, CA, 90064, bringing holistic solutions to ... , MY Education Guru has created individual programs to assist students who have ...
(Date:6/18/2019)... ... June 18, 2019 , ... Officials with American Physician ... are pleased to announce the acquisition of Leading Edge Medical Associates (LEMA), a ... physicians and 9 advanced practice clinicians care for 115,000 emergency department patients annually ...
Breaking Medicine Technology:
(Date:6/14/2019)... ... ... reviewed and approved providers for May 2019. , FL TOP DOCS INCLUDE: , BARIATRIC MEDICINE/SURGERY, ... Dr. Debbie Berlin , CARDIOLOGY, Dr. Nirat Beohar ... Dr. Yamilet Tirado , DERMATOLOGY, Dr. B. Jennifer Berkes ...
(Date:6/13/2019)... PETERSBURG, Fla. (PRWEB) , ... June 13, 2019 ... ... and research company today announced that it has signed a memorandum of understanding ... (API) for its drug product MMJ-001 and MMJ-002. , MMJ BioPharma Cultivation will ...
(Date:6/13/2019)... ... 13, 2019 , ... In Partnership with the Smiles for Everyone Foundation ... at its Mesquite, TX office on July 13th. , Dental services provided include same-day ... extractions . For more information, please visit the Monarch Dental website . , ...
(Date:6/13/2019)... ... June 13, 2019 , ... The ... present the second annual Women|Future Conference and the advisory board that ... better position themselves and their organizations in tomorrow's marketplace. , The mission of ...
(Date:6/13/2019)... ... ... Clinical Ink , a global clinical trial technology company that is ... chief business officer at Clinical Ink, has been invited to be a panelist in ... July 1, 2019, in Washington, D.C. The workshop, convened under a cooperative agreement with ...
Breaking Medicine News(10 mins):